Home LiteratureArticle Details
PMID: 1406641 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line.

Molecular and cellular biology ·Vol. 12 ·No. 10 ·1992-10-00 ·Pages 4521-30

Karnitz L, Sutor SL, Torigoe T, Reed JC, Bell MP, McKean DJ, Leibson PJ, Abraham RT

Abstract

The growth, differentiation, and functional activities of antigen-stimulated T lymphocytes are regulated by the interaction of the T-cell-derived cytokine, interleukin-2 (IL-2), with the high-affinity IL-2 receptor (IL-2R). IL-2R occupancy initiates a rapid increase in intracellular protein tyrosine phosphorylation, suggesting that a receptor-coupled protein tyrosine kinase (PTK) serves as a proximal signaling element for the IL-2R. Previous studies implicated the src-family kinase, p56lck, as a potential IL-2R-linked signal transducer. In this study, we have characterized a spontaneous variant of the IL-2-dependent cytotoxic T-cell line, CTLL-2, which contains no detectable lck-derived mRNA transcripts, protein, or PTK activity. The p56lck-deficient CTLL-2 cells retained strict dependence on IL-2 for both viability and growth, indicating that p56lck activity was not required for the transduction of IL-2-mediated mitogenic signals. However, the p56lck-deficient cells exhibited a moderate decrease in their rate of IL-2-dependent proliferation. In contrast to this relatively modest proliferative defect, the p56lck-deficient cell line displayed a profound reduction in T-cell antigen receptor-dependent cytolytic effector functions. Both the proliferative and the cytolytic defects observed in the p56lck-deficient cells were completely reversed by transfection of these cells with a wild-type lck expression vector. These results indicate that p56lck expression is not obligatory for IL-2-mediated T-cell growth stimulation; however, this PTK plays a central role in the generation T-cell-mediated cytotoxic responses.

MeSH Terms
Animals Blotting, Northern Cell Division Cloning, Molecular Cytotoxicity, Immunologic Interleukin-2/physiology Kinetics Lymphocyte Specific Protein Tyrosine Kinase p56(lck) Mice Phosphorylation Protein-Tyrosine Kinases/metabolism Proto-Oncogene Proteins/deficiency,genetics RNA, Messenger/metabolism Receptors, Antigen, T-Cell/metabolism T-Lymphocytes, Cytotoxic/physiology Transfection
Chemicals
Interleukin-2 Proto-Oncogene Proteins RNA, Messenger Receptors, Antigen, T-Cell Protein-Tyrosine Kinases Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Karnitz L
Department of Immunology, Mayo Clinic, Rochester, Minnesota 55905.
Sutor S L
Torigoe T
Reed J C
Bell M P
McKean D J
Leibson P J
Abraham R T
References (46)
46 references, click to expand
  1. IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor.
    J Immunol. 1989 Aug 1;143(3):870-6 PMID: 2787350
  2. Target cell lysis by cytotoxic T lymphocytes redirected by antibody-coated polystyrene beads.
    J Immunol. 1989 Sep 1;143(5):1461-6 PMID: 2668408
  3. Protein phosphorylation mediated by IL-2/IL-2 receptor beta-chain interaction.
    J Immunol. 1988 Jul 1;141(1):174-9 PMID: 3132502
  4. Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific tyrosine protein kinase, p56lck, reveals its oncogenic potential in fibroblasts.
    Proc Natl Acad Sci U S A. 1988 Jun;85(12):4247-51 PMID: 3380789
  5. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    J Immunol. 1985 Feb;134(2):794-801 PMID: 3871216
  6. Changes in protein phosphorylation in Rous sarcoma virus-transformed chicken embryo cells.
    Mol Cell Biol. 1981 Feb;1(2):165-78 PMID: 6100962
  7. Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.
    J Exp Med. 1983 Oct 1;158(4):1356-61 PMID: 6413638
  8. In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.
    J Immunol. 1983 Jan;130(1):222-7 PMID: 6600178
  9. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
    Biochemistry. 1979 Nov 27;18(24):5294-9 PMID: 518835
  10. Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes.
    Mol Cell Biol. 1991 Sep;11(9):4431-40 PMID: 1652056
  11. Protein tyrosine phosphorylation associated with activation of the interleukin 2 receptor.
    J Biol Chem. 1990 Apr 5;265(10):5690-4 PMID: 1690713
  12. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.
    Nature. 1991 Mar 7;350(6313):62-6 PMID: 1706070
  13. The lymphocyte-specific tyrosine protein kinase p56lck.
    Semin Immunol. 1991 May;3(3):143-52 PMID: 1909593
  14. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association.
    Science. 1991 Jun 14;252(5012):1523-8 PMID: 2047859
  15. Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs.
    Cell. 1990 Mar 9;60(5):755-65 PMID: 2107025
  16. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site.
    Mol Cell Biol. 1990 Oct;10(10):5305-13 PMID: 2118992
  17. Differential effects of interleukin-2 and interleukin-4 on protein tyrosine phosphorylation in factor-dependent murine T cells.
    Biochim Biophys Acta. 1990 May 2;1052(2):313-22 PMID: 2334739
  18. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    J Immunol. 1990 Mar 1;144(5):1767-76 PMID: 2407783
  19. Specialized protein tyrosine kinase proto-oncogenes in hematopoietic cells.
    Biochim Biophys Acta. 1989 Feb;948(3):245-62 PMID: 2465780
  20. Expression of a novel form of the fyn proto-oncogene in hematopoietic cells.
    New Biol. 1989 Oct;1(1):66-74 PMID: 2488273
  21. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    J Immunol. 1989 Jan 15;142(2):666-71 PMID: 2536060
  22. Acid and base hydrolysis of phosphoproteins bound to immobilon facilitates analysis of phosphoamino acids in gel-fractionated proteins.
    Anal Biochem. 1989 Jan;176(1):22-7 PMID: 2540676
  23. A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization.
    Cell. 1989 Dec 1;59(5):837-45 PMID: 2590941
  24. Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's.
    Science. 1989 May 5;244(4904):551-6 PMID: 2785715
  25. Two-dimensional analysis of interleukin 2-regulated tyrosine kinase activation mediated by the p70-75 beta subunit of the interleukin 2 receptor.
    J Biol Chem. 1989 Jul 25;264(21):12562-7 PMID: 2787319
  26. Identification of a monoclonal antibody specific for a murine T3 polypeptide.
    Proc Natl Acad Sci U S A. 1987 Mar;84(5):1374-8 PMID: 2950524
  27. The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities.
    Science. 1987 Oct 2;238(4823):75-8 PMID: 3116668
  28. Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2.
    J Biol Chem. 1988 May 25;263(15):6956-9 PMID: 3259228
  29. Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck).
    Mol Cell Biol. 1988 Feb;8(2):540-50 PMID: 3352600
  30. Reversal of phorbol ester-mediated reduction of cloned T lymphocyte cytolysis by interleukin 2.
    J Immunol. 1985 Jan;134(1):324-9 PMID: 3871104
  31. Induction of proliferative and cytotoxic responses in resting Lyt-2+ T cells with lectin and recombinant interleukin 2.
    Eur J Immunol. 1985 Apr;15(4):332-7 PMID: 3872800
  32. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  33. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.
    Nature. 1983 Aug 18-24;304(5927):596-602 PMID: 6308472
  34. Response of resting human peripheral blood natural killer cells to interleukin 2.
    J Exp Med. 1984 Oct 1;160(4):1147-69 PMID: 6434688
  35. Interleukin 2 dependence of human natural killer (NK) cell activity.
    J Immunol. 1983 Apr;130(4):1970-3 PMID: 6601144
  36. Long term culture of tumour-specific cytotoxic T cells.
    Nature. 1977 Jul 14;268(5616):154-6 PMID: 145543
  37. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
    J Immunol. 1990 Sep 1;145(5):1490-7 PMID: 1696599
  38. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases.
    Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7410-4 PMID: 1714601
  39. T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.
    Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1996-2000 PMID: 2000405
  40. Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase.
    Mol Cell Biol. 1990 May;10(5):1853-62 PMID: 2109184
  41. The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation.
    Oncogene. 1990 Oct;5(10):1455-62 PMID: 2250907
  42. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA.
    Cell. 1985 Dec;43(2 Pt 1):393-404 PMID: 2416464
  43. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex.
    Proc Natl Acad Sci U S A. 1989 May;86(9):3277-81 PMID: 2470098
  44. Inability of CD8 alpha' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo.
    Nature. 1989 Nov 16;342(6247):278-81 PMID: 2509945
  45. The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain.
    Cell. 1989 Nov 17;59(4):627-36 PMID: 2582490
  46. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.
    J Exp Med. 1987 Jan 1;165(1):223-38 PMID: 3098894
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1992-10-00
Pages
4521-30
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC360378
Subset
IM
Grants
NCI NIH HHS · V01-CA52995 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]